About Agilent Technologies (NYSE:A)
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:A
CUSIP00846U10
Phone408-345-8886
Debt
Debt-to-Equity Ratio0.40%
Current Ratio3.23%
Quick Ratio2.78%
Price-To-Earnings
Trailing P/E Ratio28.62
Forward P/E Ratio24.93
P/E Growth2.39
Sales & Book Value
Annual Sales$4.47 billion
Price / Sales4.87
Cash Flow$2.9575 per share
Price / Cash22.84
Book Value$15.02 per share
Price / Book4.50
Profitability
EPS (Most Recent Fiscal Year)$2.36
Net Income$684 million
Net Margins4.25%
Return on Equity17.70%
Return on Assets9.72%
Miscellaneous
Employees13,500
Outstanding Shares322,480,000
Agilent Technologies (NYSE:A) Frequently Asked Questions
What is Agilent Technologies' stock symbol?
Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."
How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?
Agilent Technologies announced a quarterly dividend on Wednesday, March 21st. Shareholders of record on Tuesday, April 3rd will be given a dividend of $0.149 per share on Wednesday, April 25th. This represents a $0.60 dividend on an annualized basis and a yield of 0.88%. The ex-dividend date of this dividend is Monday, April 2nd. View Agilent Technologies' Dividend History.
How were Agilent Technologies' earnings last quarter?
Agilent Technologies (NYSE:A) announced its earnings results on Wednesday, February, 14th. The medical research company reported $0.66 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.58 by $0.08. The medical research company earned $1.21 billion during the quarter, compared to analyst estimates of $1.16 billion. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. During the same period last year, the business earned $0.53 EPS. View Agilent Technologies' Earnings History.
When is Agilent Technologies' next earnings date?
What guidance has Agilent Technologies issued on next quarter's earnings?
Agilent Technologies issued an update on its FY18 earnings guidance on Wednesday, February, 14th. The company provided EPS guidance of $2.62-2.68 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.59. The company issued revenue guidance of $4.885-4.905 billion, compared to the consensus revenue estimate of $4.75 billion.Agilent Technologies also updated its Q2 guidance to $0.61-0.63 EPS.
What price target have analysts set for A?
13 brokerages have issued twelve-month target prices for Agilent Technologies' shares. Their forecasts range from $60.73 to $91.00. On average, they expect Agilent Technologies' share price to reach $72.21 in the next twelve months. View Analyst Ratings for Agilent Technologies.
Who are some of Agilent Technologies' key competitors?
Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bruker (BRKR), Integra lifesciences (IART), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Pacific Biosciences (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM), pSivida (EYPT) and Precipio (PRPO).
Who are Agilent Technologies' key executives?
Agilent Technologies' management team includes the folowing people:
- Mr. Michael R. McMullen, CEO, Pres & Director (Age 57)
- Mr. Didier Hirsch, Sr. VP & CFO (Age 67)
- Mr. Mark Doak, Sr. VP & Pres of Agilent CrossLab Group (Age 63)
- Mr. Patrick K. Kaltenbach, Sr. VP and Pres of Life Sciences & Applied Markets Group (LSAG) Bus. Unit (Age 55)
- Mr. Jacob Thaysen, Sr. VP and Pres of Diagnostics & Genomics Group (Age 43)
Has Agilent Technologies been receiving favorable news coverage?
Headlines about A stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Agilent Technologies earned a media sentiment score of 0.05 on Accern's scale. They also assigned media headlines about the medical research company an impact score of 45.43 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Agilent Technologies?
Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Agilent Technologies' stock price today?
One share of A stock can currently be purchased for approximately $67.55.
How big of a company is Agilent Technologies?
Agilent Technologies has a market capitalization of $22.43 billion and generates $4.47 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.36 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.
How can I contact Agilent Technologies?
Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]
MarketBeat Community Rating for Agilent Technologies (A)
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
Agilent Technologies (NYSE:A) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
13 Wall Street analysts have issued ratings and price targets for Agilent Technologies in the last 12 months. Their average twelve-month price target is $72.21, suggesting that the stock has a possible upside of 6.90%. The high price target for A is $91.00 and the low price target for A is $60.73. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.85 | 2.77 | 2.71 | 2.71 |
| Ratings Breakdown: | 0 Sell Rating(s)
2 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $72.21 | $70.5946 | $68.7664 | $65.0521 |
| Price Target Upside: | 6.90% upside | 1.69% downside | 4.74% downside | 2.73% downside |
Agilent Technologies (NYSE:A) Consensus Price Target History
Agilent Technologies (NYSE:A) Analyst Ratings History
Show:
(Data available from 4/20/2016 forward)
Agilent Technologies (NYSE:A) Dividend Information
Agilent Technologies pays an annual dividend of $0.60 per share, with a dividend yield of 0.89%. A's next quarterly dividend payment will be made on Wednesday, April 25. Agilent Technologies pays out 25.42% of its earnings out as a dividend.
| Next Dividend: | 4/25/2018 |
| Annual Dividend: | $0.60 |
| Dividend Yield: | 0.89% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 25.42% (Trailing 12 Months of Earnings)
22.14% (Based on This Year's Estimates)
20.00% (Based on Next Year's Estimates)
|
| Track Record: | 2 Years of Consecutive Dividend Growth |
| Frequency: | Quarterly Dividend |
Agilent Technologies (NYSE:A) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/21/2018 | quarterly | $0.1490 | 0.89% | 4/2/2018 | 4/3/2018 | 4/25/2018 |
| 11/15/2017 | quarterly | $0.1490 | 0.87% | 12/29/2017 | 1/2/2018 | 1/24/2018 |
| 9/20/2017 | quarterly | $0.1320 | 0.8% | 10/2/2017 | 10/3/2017 | 10/25/2017 |
| 5/17/2017 | quarterly | $0.1320 | 0.95% | 6/29/2017 | 7/3/2017 | 7/26/2017 |
| 3/15/2017 | quarterly | $0.1320 | 1% | 3/31/2017 | 4/4/2017 | 4/26/2017 |
| 11/17/2016 | quarterly | $0.1320 | 1.17% | 12/29/2016 | 1/3/2017 | 1/25/2017 |
| 9/21/2016 | quarterly | $0.1150 | 0.99% | 9/30/2016 | 10/4/2016 | 10/26/2016 |
| 5/18/2016 | quarterly | $0.1150 | 1.03% | 6/30/2016 | 7/5/2016 | 7/27/2016 |
| 3/16/2016 | quarterly | $0.1150 | 1.17% | 4/1/2016 | 4/5/2016 | 4/27/2016 |
| 11/19/2015 | quarterly | $0.1150 | 1.17% | 12/31/2015 | 1/5/2016 | 1/27/2016 |
| 9/16/2015 | quarterly | $0.10 | 1.1% | 9/25/2015 | 9/29/2015 | 10/21/2015 |
| 5/20/2015 | quarterly | $0.10 | 0.95% | 6/26/2015 | 6/30/2015 | 7/22/2015 |
| 3/18/2015 | quarterly | $0.10 | 0.95% | 3/27/2015 | 3/31/2015 | 4/22/2015 |
| 11/20/2014 | quarterly | $0.10 | 0.95% | 1/2/2015 | 1/6/2015 | 1/28/2015 |
| 9/17/2014 | quarterly | $0.1320 | 0.9% | 9/26/2014 | 9/30/2014 | 10/22/2014 |
| 5/22/2014 | quarterly | $0.1320 | 0.94% | 6/27/2014 | 7/1/2014 | 7/23/2014 |
| 4/1/2014 | quarterly | $0.13 | 0.93% | 4/9/2014 | 4/11/2014 | 4/23/2014 |
| 11/22/2013 | quarterly | $0.1320 | 0.99% | 12/27/2013 | 12/31/2013 | 1/22/2014 |
| 9/18/2013 | quarterly | $0.12 | 0.94% | 9/27/2013 | 10/1/2013 | 10/23/2013 |
| 5/23/2013 | quarterly | $0.12 | 1.05% | 6/28/2013 | 7/2/2013 | 7/24/2013 |
| 1/17/2013 | quarterly | $0.12 | 1.09% | 3/28/2013 | 4/2/2013 | 4/24/2013 |
(Data available from 1/1/2013 forward)
Agilent Technologies (NYSE A) Insider Trading and Institutional Ownership History
Agilent Technologies (NYSE A) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/29/2018 | Patrick Kaltenbach | Insider | Sell | 4,000 | $67.28 | $269,120.00 | 72,547 |  |
| 3/27/2018 | Heidi Fields | Director | Sell | 5,000 | $68.09 | $340,450.00 | 57,563 | |
| 3/13/2018 | Rodney Gonsalves | VP | Sell | 6,825 | $71.23 | $486,144.75 | | |
| 3/12/2018 | Patrick Kaltenbach | Insider | Sell | 6,875 | $71.38 | $490,737.50 | | |
| 1/29/2018 | Michael R Mcmullen | CEO | Sell | 21,850 | $75.00 | $1,638,750.00 | 324,687 | |
| 1/18/2018 | Michael R Mcmullen | CEO | Sell | 21,850 | $72.50 | $1,584,125.00 | 324,687 | |
| 1/5/2018 | Michael R Mcmullen | CEO | Sell | 43,703 | $70.00 | $3,059,210.00 | 302,837 | |
| 12/18/2017 | Mark Doak | Insider | Sell | 15,567 | $68.00 | $1,058,556.00 | 71,104 | |
| 12/5/2017 | Mark Doak | VP | Sell | 4,154 | $67.00 | $278,318.00 | 68,270 | |
| 11/28/2017 | Jacob Thaysen | SVP | Sell | 22,583 | $70.41 | $1,590,069.03 | 63,042 | |
| 11/28/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $69.56 | $347,800.00 | 75,504 | |
| 11/27/2017 | Didier Hirsch | CFO | Sell | 20,000 | $69.40 | $1,388,000.00 | 204,851 | |
| 11/22/2017 | Didier Hirsch | CFO | Sell | 12,964 | $69.00 | $894,516.00 | 184,851 | |
| 11/22/2017 | Patrick Kaltenbach | Insider | Sell | 7,358 | $69.28 | $509,762.24 | 72,862 | |
| 11/20/2017 | Michael R Mcmullen | CEO | Sell | 22,481 | $70.00 | $1,573,670.00 | 327,882 | |
| 11/17/2017 | Michael R Mcmullen | CEO | Sell | 22,481 | $68.77 | $1,546,018.37 | 336,637 | |
| 9/15/2017 | Didier Hirsch | CFO | Sell | 15,555 | $66.00 | $1,026,630.00 | 178,557 | |
| 9/14/2017 | Michael R Mcmullen | CEO | Sell | 16,492 | $65.33 | $1,077,422.36 | 211,872 | |
| 9/13/2017 | Didier Hirsch | CFO | Sell | 1,200 | $66.00 | $79,200.00 | 164,202 | |
| 9/8/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $65.26 | $326,300.00 | 45,143 | |
| 8/31/2017 | Didier Hirsch | CFO | Sell | 20,000 | $64.00 | $1,280,000.00 | 183,002 | |
| 8/30/2017 | Boon Hwee Koh | Director | Sell | 4,500 | $63.63 | $286,335.00 | | |
| 8/23/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $63.26 | $316,300.00 | | |
| 8/22/2017 | Didier Hirsch | CFO | Sell | 72,545 | $62.38 | $4,525,357.10 | | |
| 8/18/2017 | Mark Doak | Insider | Sell | 12,421 | $61.57 | $764,760.97 | | |
| 8/16/2017 | Dominique Grau | Insider | Sell | 13,007 | $62.00 | $806,434.00 | 60,098 | |
| 7/13/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $61.26 | $306,300.00 | 45,138 | |
| 6/16/2017 | Heidi Fields | Director | Sell | 8,625 | $59.53 | $513,446.25 | | |
| 6/1/2017 | Didier Hirsch | CFO | Sell | 5,710 | $60.60 | $346,026.00 | | |
| 5/31/2017 | Patrick Kaltenbach | Insider | Sell | 2,074 | $60.43 | $125,331.82 | 42,212 | |
| 5/30/2017 | Mark Doak | Insider | Sell | 21,851 | $60.00 | $1,311,060.00 | | |
| 5/25/2017 | Paul N. Clark | Director | Sell | 3,866 | $59.05 | $228,287.30 | | |
| 5/24/2017 | James Cullen | Director | Sell | 15,482 | $59.04 | $914,057.28 | | |
| 5/23/2017 | Michael R. Mcmullen | CEO | Sell | 50,000 | $59.86 | $2,993,000.00 | | |
| 5/4/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $56.50 | $282,500.00 | | |
| 5/1/2017 | Michael R Mcmullen | CEO | Sell | 32,511 | $55.48 | $1,803,710.28 | 260,346 | |
| 4/24/2017 | Patrick Kaltenbach | Insider | Sell | 2,000 | $54.50 | $109,000.00 | 42,132 | |
| 4/10/2017 | Patrick Kaltenbach | Insider | Sell | 2,000 | $52.90 | $105,800.00 | 42,132 | |
| 3/27/2017 | Mark Doak | Insider | Sell | 3,607 | $53.14 | $191,675.98 | | |
| 3/10/2017 | Rodney Gonsalves | VP | Sell | 8,496 | $52.05 | $442,216.80 | | |
| 2/16/2017 | Patrick Kaltenbach | Insider | Sell | 3,771 | $51.68 | $194,885.28 | | |
| 2/15/2017 | Didier Hirsch | CFO | Sell | 22,258 | $51.50 | $1,146,287.00 | 190,285 | |
| 2/9/2017 | Didier Hirsch | CFO | Sell | 22,256 | $50.50 | $1,123,928.00 | 190,283 | |
| 2/1/2017 | Didier Hirsch | CFO | Sell | 22,256 | $49.50 | $1,101,672.00 | | |
| 1/9/2017 | Didier Hirsch | CFO | Sell | 22,256 | $48.50 | $1,079,416.00 | 190,023 | |
| 12/9/2016 | Mark Doak | Insider | Sell | 3,969 | $46.00 | $182,574.00 | 54,626 | |
| 11/18/2016 | Paul N. Clark | Director | Sell | 4,704 | $45.31 | $213,138.24 | | |
| 9/30/2016 | Patrick Kaltenbach | Insider | Sell | 2,000 | $47.30 | $94,600.00 | 22,463 | |
| 9/6/2016 | Heidi Fields | Director | Sell | 8,072 | $46.99 | $379,303.28 | 51,836 | |
| 8/31/2016 | Patrick Kaltenbach | Insider | Sell | 2,000 | $47.00 | $94,000.00 | 22,463 | |
| 8/29/2016 | Rodney Gonsalves | VP | Sell | 8,141 | $47.82 | $389,302.62 | 16,322 | |
| 8/24/2016 | Boon Hwee Koh | Director | Sell | 5,298 | $47.66 | $252,502.68 | | |
| 8/22/2016 | James Cullen | Director | Sell | 13,574 | $47.52 | $645,036.48 | | |
| 5/27/2016 | James Cullen | Director | Sell | 16,697 | $45.78 | $764,388.66 | 92,613 | |
| 5/23/2016 | James Cullen | Director | Sell | 16,922 | $44.63 | $755,228.86 | 84,541 | |
| 5/19/2016 | Mark Doak | VP | Sell | 18,879 | $44.14 | $833,319.06 | 30,827 | |
| 5/19/2016 | Michael R Mcmullen | CEO | Sell | 124,411 | $44.46 | $5,531,313.06 | 171,473 | |
| 5/19/2016 | Patrick Kaltenbach | SVP | Sell | 5,266 | $44.07 | $232,072.62 | 25,729 | |
| 5/18/2016 | Rodney Gonsalves | VP | Sell | 9,542 | $44.24 | $422,138.08 | 16,322 | |
| 5/11/2016 | Dominique Grau | SVP | Sell | 10,322 | $43.00 | $443,846.00 | 46,268 | |
| 4/14/2016 | Dominique Grau | SVP | Sell | 10,321 | $41.00 | $423,161.00 | 46,267 | |
| 3/31/2016 | Dominique Grau | SVP | Sell | 10,321 | $40.00 | $412,840.00 | 46,267 | |
| 3/31/2016 | Heidi Fields | Director | Sell | 30,000 | $39.91 | $1,197,300.00 | 57,312 | |
| 3/18/2016 | Robert J Herbold | Director | Sell | 8,072 | $40.30 | $325,301.60 | | |
| 6/29/2015 | Boon Hwee Koh | Director | Sell | 5,000 | $39.61 | $198,050.00 | | |
| 6/26/2015 | Mark Doak | VP | Sell | 7,938 | $40.01 | $317,599.38 | | |
| 6/25/2015 | Robert J Herbold | Director | Sell | 8,870 | $40.00 | $354,800.00 | | |
| 4/14/2015 | Michael R Mcmullen | CEO | Sell | 43,130 | $42.72 | $1,842,513.60 | | |
| 3/10/2015 | A Barry Rand | Director | Sell | 8,870 | $40.95 | $363,226.50 | | |
| 3/4/2015 | Paul N Clark | Director | Sell | 37,973 | $41.87 | $1,589,929.51 | | |
| 3/3/2015 | Patrick Kaltenbach | SVP | Sell | 1,149 | $42.41 | $48,729.09 | | |
| 3/2/2015 | Dominique Grau | SVP | Sell | 10,949 | $42.63 | $466,755.87 | | |
| 2/20/2015 | Solange Glaize | CAO | Sell | 32,700 | $41.78 | $1,366,206.00 | | |
| 12/1/2014 | William P Sullivan | CEO | Sell | 43,667 | $41.83 | $1,826,590.61 | | |
| 9/30/2014 | Heidi Fields | Director | Sell | 5,032 | $57.17 | $287,679.44 | | |
| 9/29/2014 | Didier Hirsch | CFO | Sell | 25,237 | $56.96 | $1,437,499.52 | | |
| 9/26/2014 | William P Sullivan | CEO | Sell | 494,887 | $56.45 | $27,936,371.15 | | |
| 9/19/2014 | Didier Hirsch | CFO | Sell | 24,051 | $58.48 | $1,406,502.48 | | |
| 6/23/2014 | Michael R Mcmullen | SVP | Sell | 35,377 | $58.56 | $2,071,677.12 | | |
| 6/17/2014 | Jean Halloran | SVP | Sell | 78,130 | $59.13 | $4,619,826.90 | | |
| 3/21/2014 | Marie Oh Huber | SVP | Sell | 60,567 | $56.60 | $3,428,092.20 | 32,582 | |
| 3/12/2014 | William Sullivan | CEO | Sell | 231,092 | $56.66 | $13,093,672.72 | 401,638 | |
| 2/21/2014 | Heidi Fields | Director | Sell | 3,464 | $56.80 | $196,755.20 | 51,620 | |
| 12/30/2013 | Michael Mcmullen | SVP | Sell | 4,402 | $57.39 | $252,630.78 | 76,213 | |
| 12/18/2013 | Didier Hirsch | CFO | Sell | 25,539 | $56.61 | $1,445,762.79 | 59,325 | |
| 12/6/2013 | Jean Halloran | SVP | Sell | 55,127 | $53.82 | $2,966,935.14 | 75,545 | |
| 11/20/2013 | Boon Hwee Koh | Director | Sell | 5,651 | $53.77 | $303,854.27 | 47,276 | |
| 9/23/2013 | Marie Oh Huber | SVP | Sell | 40,516 | $51.82 | $2,099,539.12 | 25,264 | |
| 9/20/2013 | Didier Hirsch | CFO | Sell | 17,327 | $52.00 | $901,004.00 | 54,412 | |
| 9/20/2013 | Ronald Nersesian | EVP | Sell | 181,480 | $51.92 | $9,422,441.60 | 46,339 | |
| 9/19/2013 | Michael Mcmullen | SVP | Sell | 10,000 | $52.48 | $524,800.00 | 91,102 | |
| 6/19/2013 | Michael R Mcmullen | SVP | Sell | 43,253 | $44.66 | $1,931,678.98 | | |
| 5/22/2013 | Didier Hirsch | CFO | Sell | 10,002 | $47.00 | $470,094.00 | | |
| 5/17/2013 | James Cullen | Director | Sell | 8,329 | $45.31 | $377,386.99 | | |
| 8/28/2012 | Heidi Fields | Director | Buy | 1,755 | $37.21 | $65,303.55 | | |
(Data available from 1/1/2013 forward)
Agilent Technologies (NYSE A) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Worldwide Microarray Analysis Market | Rapid Marvelous Grow at a CAGR 9.8% | Future Outlook 2023
www.marketwatch.com - April 20 at 9:04 AM |
 | Agilent Technologies (A) Upgraded at BidaskClub
www.americanbankingnews.com - April 19 at 2:24 PM |
| Agilent Technologies (A) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 19 at 11:29 AM |
| Agilent Technologies (A) Expected to Announce Quarterly Sales of $1.21 Billion
www.americanbankingnews.com - April 19 at 2:10 AM |
 | BRIEF-Agilent Technologies Files Civil Lawsuit Against Pannatek, Including Former Agilent Employee
www.reuters.com - April 18 at 5:09 PM |
 | Agilent Technologies Files Second Civil Action to Protect Intellectual Property
finance.yahoo.com - April 18 at 5:09 PM |
| Zacks: Analysts Anticipate Agilent Technologies (A) Will Announce Earnings of $0.64 Per Share
www.americanbankingnews.com - April 17 at 9:10 PM |
| Agilent Technologies' (A) Buy Rating Reiterated at Barclays
www.americanbankingnews.com - April 17 at 4:47 PM |
| BidaskClub Downgrades Agilent Technologies (A) to Buy
www.americanbankingnews.com - April 15 at 12:37 AM |
| Where Agilent Technologies Inc’s (NYSE:A) Earnings Growth Stands Against Its Industry
finance.yahoo.com - April 12 at 4:58 PM |
| Qualcomm Arms IoT Devices With Vision Intelligence Platform
finance.yahoo.com - April 12 at 4:58 PM |
| Semtech (SMTC) Hits 52-Week High on Bullish Growth Trends
finance.yahoo.com - April 11 at 4:55 PM |
| Agilent Technologies (A) Price Target Cut to $91.00
www.americanbankingnews.com - April 11 at 9:23 AM |
| Strong Product Portfolio Aids AMETEK (AME), Risks Persist
finance.yahoo.com - April 9 at 4:50 PM |
| Adobe (ADBE) Promotes Murphy as New Chief Financial Officer
finance.yahoo.com - April 9 at 9:08 AM |
| Agilent Technologies (A) Lifted to Buy at Goldman Sachs
www.americanbankingnews.com - April 9 at 8:12 AM |
 | Global Microfluidic Chips Market 2018-2022 - Key Vendors are Agilent Technologies, Fluidigm, Fluigent, MicruX Fluidic ...
www.businesswire.com - April 8 at 5:16 PM |
| Agilent Technologies (A) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 7 at 5:30 PM |
| Agilent Teams Up With BioTek, Expands Product Portfolio
finance.yahoo.com - April 6 at 5:07 PM |
| Itron Meters to Upgrade Fort Smith City Water Infrastructure
finance.yahoo.com - April 6 at 5:07 PM |
| Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform
finance.yahoo.com - April 4 at 3:41 PM |
| Agilent to Acquire Lasergen for $105M, Strengthens Portfolio
finance.yahoo.com - April 4 at 3:41 PM |
| Agilent Technologies (A) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - April 4 at 12:24 PM |
| Agilent Technologies (A) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - April 4 at 11:15 AM |
| BRIEF-Agilent Technologies Agrees To Buy Lasergen For $105 Mln
www.reuters.com - April 4 at 8:58 AM |
| Agilent Technologies Signs Agreement to Acquire Lasergen, Inc.
finance.yahoo.com - April 3 at 4:56 PM |
| Global Gas Chromatography Market Opportunities 2018:Agilent Technologies, PerkinElmer, Shimadzu Corporation
www.marketwatch.com - April 3 at 9:07 AM |
| Agilent Technologies (A) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 2 at 7:30 PM |
| Agilent Technologies (A) Given New $95.00 Price Target at Morgan Stanley
www.americanbankingnews.com - April 2 at 9:04 AM |
| $1.21 Billion in Sales Expected for Agilent Technologies (A) This Quarter
www.americanbankingnews.com - April 2 at 1:48 AM |
| Head to Head Survey: Mettler-Toledo International (MTD) vs. Agilent Technologies (A)
www.americanbankingnews.com - March 31 at 11:30 PM |
| Analysts Anticipate Agilent Technologies (A) to Announce $0.64 EPS
www.americanbankingnews.com - March 31 at 11:12 PM |
| Insider Selling: Agilent Technologies Inc (A) Insider Sells 4,000 Shares of Stock
www.americanbankingnews.com - March 29 at 10:30 PM |
| Is Agilent Technologies Inc’s (NYSE:A) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - March 29 at 4:55 PM |
| Agilent Technologies Inc (A) Director Sells $340,450.00 in Stock
www.americanbankingnews.com - March 28 at 4:20 PM |
| Agilent Technologies (A) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - March 27 at 1:51 PM |
| Agilent Technologies (A) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 26 at 3:13 PM |
| Agilent Technologies Inc (A) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - March 25 at 11:41 AM |
 | Global Forensic Technologies Market Will Reach USD 10,929.51 Million by 2023: Zion Market Research
globenewswire.com - March 24 at 4:47 PM |
| Agilent Technologies (A) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - March 24 at 2:02 PM |
 | Agree To Purchase Agilent Technologies At $60, Earn 5.4% Annualized Using Options - Nasdaq
www.nasdaq.com - March 23 at 5:01 PM |
| Global Bioinformatics Market Opportunities 2018: Biomax Informatics AG, Agilent Technologies, QIAGEN N.V.
www.marketwatch.com - March 21 at 5:06 PM |
| Agilent Technologies Announces Cash Dividend of 14.9 Cents per Share
finance.yahoo.com - March 21 at 5:06 PM |
| Agilent Technologies Inc to Issue Quarterly Dividend of $0.15 (A)
www.americanbankingnews.com - March 21 at 4:44 PM |
| Agilent (A) Down 2.6% Since Earnings Report: Can It Rebound?
finance.yahoo.com - March 16 at 5:54 PM |
 | This Morning's Technical Outlook on Medical Research Stocks -- Agilent Technologies, BioTelemetry, Accelerate Diagnostics, and Biocept
www.bizjournals.com - March 16 at 9:06 AM |
| $1.21 Billion in Sales Expected for Agilent Technologies Inc (A) This Quarter
www.americanbankingnews.com - March 16 at 3:26 AM |
| Agilent Introduces New Color for Cancer Diagnosis
finance.yahoo.com - March 15 at 5:28 PM |
| Agilent Technologies Inc (A) VP Sells $486,144.75 in Stock
www.americanbankingnews.com - March 14 at 7:28 PM |
| Agilent Technologies Inc (A) Insider Sells $490,737.50 in Stock
www.americanbankingnews.com - March 14 at 10:18 AM |
Agilent Technologies (NYSE:A) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Agilent Technologies (NYSE:A) Income Statement, Balance Sheet and Cash Flow Statement
Agilent Technologies (NYSE A) Stock Chart for Friday, April, 20, 2018
Loading chart…
